NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 216 filers reported holding NEKTAR THERAPEUTICS in Q4 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $0 | -100.0% | 250 | -42.5% | 0.00% | – |
Q2 2022 | $1,000 | -50.0% | 435 | 0.0% | 0.00% | – |
Q1 2022 | $2,000 | -60.0% | 435 | 0.0% | 0.00% | – |
Q4 2021 | $5,000 | -44.4% | 435 | -18.7% | 0.00% | – |
Q3 2021 | $9,000 | 0.0% | 535 | 0.0% | 0.00% | – |
Q2 2021 | $9,000 | -10.0% | 535 | 0.0% | 0.00% | – |
Q1 2021 | $10,000 | 0.0% | 535 | 0.0% | 0.00% | – |
Q4 2020 | $10,000 | -33.3% | 535 | -40.7% | 0.00% | -100.0% |
Q3 2020 | $15,000 | -21.1% | 902 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $19,000 | +26.7% | 902 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $15,000 | -21.1% | 902 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $19,000 | +18.8% | 902 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $16,000 | -56.8% | 902 | -14.3% | 0.00% | -50.0% |
Q2 2019 | $37,000 | -2.6% | 1,052 | -8.7% | 0.00% | -33.3% |
Q1 2019 | $38,000 | 0.0% | 1,152 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $38,000 | -49.3% | 1,152 | -6.5% | 0.00% | -40.0% |
Q3 2018 | $75,000 | +25.0% | 1,232 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $60,000 | -11.8% | 1,232 | +92.2% | 0.01% | -16.7% |
Q1 2018 | $68,000 | – | 641 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
CM Management, LLC | 50,000 | $160,000 | 0.18% |
TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |